Hugh Calkins, AF Symposium 2021: Atrial Fibrillation and HFrEF and HFpEF
We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about atrial fibrillation and heart failure with reduced and preserved ejection fraction.
Questions:
- What is the prevalence of atrial fibrillation (AF) in patients with heart failure (HF) and reduced (HFrEF) and preserved (HFpEF) ejection fraction? (0.13)
- What is the impact of AF on prognosis in patients with HFpEF and HFrEF? (1.14)
- What factors should be considered when prescribing therapies for patients with AF and HF? (2.12)
- How does treatment of AF impact HFpEF outcomes? (3.07)
Speaker disclosures: Professor Hugh Calkins is a consultant and/or has received honoraria from Atricure, Biosense Webster, Abbott, Medtronic and Ablacon.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Hugh Calkins as a highlight of the AF Symposium, January 2021.
